XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3

Interest in joint venture (Tables)

9 Months Ended

Sep. 30, 2023

Interests In Other Entities [Abstract]

Schedule of movement in interest in joint venture

The table below provides a rollforward of the Company’s interest in Overland ADCT BioPharma as of September 30, 2023 and 2022, respectively.

(in KUSD)
Interest in joint venture
January 1, 2023						31,152
Share of comprehensive loss in joint venture						(4,163)
September 30, 2023						26,989
January 1, 2022						41,236
Share of comprehensive loss in joint venture						(6,549)
September 30, 2022						34,687

Summary of financial information in join venture

The tables below provide summarized financial information for Overland ADCT BioPharma that is material to the Company. The following information reflects the amounts presented in the financial statements of Overland ADCT BioPharma and not the Company’s share of those amounts.

(in KUSD)						As of
Summarized Balance Sheet						September 30, 2023						December 31, 2022
Cash and cash equivalents						9,238						19,261
Prepaid and other current assets						364						2
Intangible assets						49,249						49,249
Total liabilities						(3,553)						(3,062)
Net assets						55,298						65,450
Summarized Statement of Comprehensive Loss						Three months ended September 30,												Nine months ended September 30,
						2023						2022						2023						2022
Loss from operations						2,750						4,950						8,278						14,317
Other expense (income)						126						(604)						(1,057)						(1,308)
Other comprehensive loss (income)						(157)						—						1,274						—
Total comprehensive loss						2,719						4,346						8,495						13,009

X

- Definition

Interests In Other Entities [Abstract]

+ References

No definition available.

+ Details

Name:	adc_InterestsInOtherEntitiesAbstract
Namespace Prefix:	adc_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of interests in joint arrangements. A joint arrangement is an arrangement of which two or more parties have joint control.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph 2
-Subparagraph b
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_2_b_ii&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_DisclosureOfInterestsInJointArrangementsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the reconciliation of the summarised financial information of a joint venture accounted for using the equity method to the carrying amount of the reporting entity's interest in the joint venture. [Refer: Carrying amount [member]; Joint ventures [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B14
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B14_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_DisclosureOfReconciliationOfSummarisedFinancialInformationOfJointVentureAccountedForUsingEquityMethodToCarryingAmountOfInterestInJointVentureExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration